(2023)
Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma.
BIOMEDICINE & PHARMACOTHERAPY.
168,
(2023)
Rechallenge with Anti-PD-1 Inhibitors in Patients with Recurrent Gynecologic Malignancies.
YONSEI MEDICAL JOURNAL.
64,
10
(2023)
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer.
JOURNAL OF GYNECOLOGIC ONCOLOGY.
34,
5
(2023)
The Effect of Intrathecal Morphine on Postoperative Opioid Consumption in Patients Undergoing Abdominal Surgery for Gynecologic Malignancy: A Randomized Sham-Controlled Trial.
ANESTHESIA AND ANALGESIA.
137,
3
(2023)
Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles Encapsulating Fenbendazole and Rapamycin in Ovarian Cancer.
INTERNATIONAL JOURNAL OF NANOMEDICINE.
18,
(2023)
High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.
BIOMATERIALS.
296,
(2023)
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
Nature Communications.
14,
1
(2023)
Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction during Primary Cytoreductive Surgery for Advanced Ovarian cancer.
CLINICAL NUCLEAR MEDICINE.
48,
2
(2023)
Arteriovenous Malformation Associated with Intravenous Leiomyomatosis of the Uterus: Characteristic CT Findings and Treatment by Embolization and Surgery.
Journal of Vascular and Interventional Radiology.
34,
1
(2023)
Role of salvage radiotherapy for recurrent ovarian cancer.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.
33,
1
(2022)
Invisible cervical cancers on MRI: Can the type of histology (SCC versus non-SCC) influence surgical planning?.
FRONTIERS IN ONCOLOGY.
12,
-
(2022)
Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.
32,
12
(2022)
Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers.
CANCER RESEARCH AND TREATMENT.
54,
4
(2022)
Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047).
INTERNATIONAL JOURNAL OF CANCER.
151,
7
(2022)
Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer.
FRONTIERS IN ONCOLOGY.
12,
(2022)
Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases.
CANCER BIOMARKERS.
35,
1
(2022)
Anticancer Activity of the Combination of Cabozantinib and Temozolomide in Uterine Sarcoma.
CLINICAL CANCER RESEARCH.
28,
17
(2022)
Impact of bevacizumab and secondary cytoreductive surgery on survival outcomes in platinum-sensitive relapsed ovarian clear cell carcinoma: A multicenter study in Korea.
GYNECOLOGIC ONCOLOGY.
166,
3
(2022)
The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching.
CANCERS.
14,
16
(2022)
Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery.
GYNECOLOGIC ONCOLOGY.
165,
3
(2018)
Use of NGS panel for precision medicine in gynecologic oncology (17:35~17:50).
대한부인종양학회 제33차 춘계학술대회.
KOREA, REPUBLIC OF
(2017)
Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising in endometriosis.
12th Congress of the European Society of Gynecology.
SPAIN
(2017)
Anti-cancer effect of axitinib in ovarian cancer.
제103차 대한산부인과학회 학술대회.
KOREA, REPUBLIC OF
(2017)
Visanne - Scientific evidence in the treatment of endometiosis.
제11차 부인종양을 연구하는 젊은의사들을 위한 워크샵, 제1차 부인종양분과전문의 연수강좌.
KOREA, REPUBLIC OF
(2017)
Introduction to the practice guidelines and national program of HPV vaccination in Koreain Korea.
25th Asian & Oceanic Congress of Obstetrics and Gynaecology.
HONG KONG
(2017)
Differences in correlation of progression-free survival and overall survival by clinical variables in epithelial ovarian cancer.
25th Asian & Oceanic Congress of Obstetrics and Gynaecology.
HONG KONG
(2017)
Pre-rolled TachoSil for minimal invasive surgery.
대한산부인과내시경.최소침습수술학회 제17차 춘계연수강좌.
KOREA, REPUBLIC OF
(2017)
Combination of cisplatin and chloroquine increases cell death through inhibiting ATR activity in cisplatin-resistant ovarian cancer cells.
제32차 대한부인종양학회 춘계학술대회.
KOREA, REPUBLIC OF
(2016)
SMC experience of MTB in GYN oncology.
대한부인암중개연구회 학술대회.
KOREA, REPUBLIC OF
(2016)
Dynamin 2 inhibitors as novel therapeutic agents in cervical cancer cells.
EUROGIN 2016 Congress.
AUSTRIA
(2016)
Translational model for precision medicine in gynecologic cancer.
대한부인종양학회 제31차 춘계학술대회.
KOREA, REPUBLIC OF
(2016)
Ovarian cancer translational research.
대한부인암중개연구회심포지움.
KOREA, REPUBLIC OF
(2015)
전문의 전문과목별 공통 및 전문역량 연구 -산부인과-.
대한의학회 -제14기 학회 임원 아카데미.
KOREA, REPUBLIC OF
(2015)
Drug repositioning: a new therapeutic strategy for ovarian cancer.
The 4th Biennial Meeting of ASGO.
KOREA, REPUBLIC OF
(2015)
Differences in survival outcome of recurrent epithelial ovarian cancer patients with secondary cytoreductive surgery diagnosed recurrence by different initial diagnostic method.
The 4th Biennial Meeting of ASGO.
KOREA, REPUBLIC OF
(2015)
IGFBP-5 derived peptide as a novel angiogenesis inhibitor for treatment of ovarian cancer.
The 4th Biennial Meeting of ASGO.
KOREA, REPUBLIC OF
(2015)
Outcomes of laparoscopic fertility-spariang surgery in presumed early-stage epithelial ovarian cancer.
The 4th Biennial Meeting of ASGO.
KOREA, REPUBLIC OF
(2015)
Prognostic factors affecting survival in cervical cancer patients who had recurrent parenchymal lung lesion.
The 4th Biennial Meeting of ASGO.
KOREA, REPUBLIC OF
(2015)
Prognostic value of preoperative total lesion glycolysis in patients with uterine carcinosarcoma.
The 4th Biennial Meeting of ASGO.
KOREA, REPUBLIC OF
(2015)
Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
The 4th Biennial Meeting of ASGO.
KOREA, REPUBLIC OF